Clinical Trial Update: Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

View source ↗

Summary

This clinical trial update reports the results of a completed study evaluating bevacizumab in combination with front-line chemotherapy for ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Ovarian Cancer | Status: COMPLETED